Clinical trial
Chemotherapy Followed By Vaccine Therapy in Treating Patients With…
NCT00049218 · H. Lee Moffitt Cancer Center and Research Institute, Other · Completed
Key facts
| NCT number | NCT00049218 |
|---|---|
| Title | Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
| Official title | A Phase I-II Trial Using Dendritic Cells Transduced With An Adenoviral Vector Containing The p53 Gene To Immunize Patients With Extensive Stage Small Cell Lung Cancer After Standard Chemotherapy |
| Lead sponsor | H. Lee Moffitt Cancer Center and Research Institute, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Biological, Drug |
| Interventions | Autologous dendritic cell-adenovirus p53 vaccine, Carboplatin, Etoposide |
| Enrollment | 56 |
| Start date | Apr 1, 2003 |
| Primary completion | Jun 1, 2007 |
| Completion | May 1, 2014 |
| First posted | Jan 27, 2003 |
| Last update posted | May 9, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: